Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
Phase 3
Completed
- Conditions
- Alzheimer's DiseaseDementia
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2010-04-28
- Target Recruit Count
- 554
- Registration Number
- NCT00338117
An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks
Phase 2
Completed
- Conditions
- ChemotherapyAnemiaCancer
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 129
- Registration Number
- NCT00337948
An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
Phase 2
Completed
- Conditions
- CancerAnemia
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 115
- Registration Number
- NCT00338416
Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia
Phase 2
Completed
- Conditions
- AnemiaChemotherapy
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2011-05-23
- Target Recruit Count
- 51
- Registration Number
- NCT00338299
A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
Phase 2
Completed
- Conditions
- Renal Failure , ChronicAnemia
- Interventions
- Other: Standard of care
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2013-05-13
- Target Recruit Count
- 157
- Registration Number
- NCT00337935
Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 399
- Registration Number
- NCT00334126
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Completed
- Conditions
- ContraceptionFemale Contraception
- Interventions
- Drug: Monophasic or triphasic Oral contraceptive tabletDrug: Ortho Evra transdermal patch containing 6 mg NGMN/0.75 mg EE
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2016-07-19
- Target Recruit Count
- 334
- Registration Number
- NCT00331071
A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
Phase 3
Completed
- Conditions
- Bipolar DisorderMood Disorders
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2014-06-20
- Target Recruit Count
- 493
- Registration Number
- NCT00309699
A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.
Phase 3
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 139
- Registration Number
- NCT00309725
A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
Phase 3
Completed
- Conditions
- Affective Psychosis, BipolarBipolar DisorderMania
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 300
- Registration Number
- NCT00309686
© Copyright 2025. All Rights Reserved by MedPath